Jing Ji

3.0k total citations
126 papers, 2.2k citations indexed

About

Jing Ji is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jing Ji has authored 126 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Jing Ji's work include Ubiquitin and proteasome pathways (8 papers), RNA modifications and cancer (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Jing Ji is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), RNA modifications and cancer (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Jing Ji collaborates with scholars based in China, United States and Canada. Jing Ji's co-authors include Peng‐Sheng Zheng, Hui Ji, Qinghua Hu, Xiaoyan Wang, Xiaogang Zhang, Kuibo Yin, Jie Wang, Hongsen Li, Laifa Shen and Jianmin Miao and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Molecular Cell.

In The Last Decade

Jing Ji

116 papers receiving 2.2k citations

Peers

Countries citing papers authored by Jing Ji

Since Specialization

Citations

This map shows the geographic impact of Jing Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Ji more than expected).

Fields of papers citing papers by Jing Ji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Ji. The network helps show where Jing Ji may publish in the future.

Co-authorship network of co-authors of Jing Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Ji. A scholar is included among the top collaborators of Jing Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Ji. Jing Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cancer-associated fibroblasts (CAFs) derived from MFAP2 promote CRC proliferation and metastasis while suppressing CD8+ T cell-mediated antitumor immunity 2026 ·Cell Death and Disease ·Xi Zhang, Yuxiang Fei, (unknown), (unknown), (unknown), Jie Wang, (unknown), (unknown), (unknown), Jing Ji, (unknown), Chaoying Liu	0
2	Seismic behavior of precast concrete beam-column subassemblies with joint rebar couplers 2025 ·Structures ·Zeyu Chen, Xiaolei Han, Xiang Wang, (unknown), Guoxian Huang, (unknown), Jing Ji	0
3	Flexural performance of RC beams strengthened with prestressed BFRP grid and PVA-ECC 2025 ·Structures ·Jing Ji, Shuaiqi Wang, (unknown), Xiaomeng Hou, Daiyu Wang, Jinjin He, Ju Qiu, (unknown)	1
4	Design, synthesis and antitumor activity of novel 4-oxobutanamide derivatives 2024 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Jingliang He, (unknown), (unknown), Siqi Wang, Dongfeng Xue, Lili Yan, Ruiying Wang, (unknown), Zhiyu Liu, (unknown), (unknown), (unknown), Yifei Gu, Jing Ji	0
5	Curcumin as a promising treatment for pulmonary fibrosis: Mechanism and therapeutic potential 2024 ·Pharmacological Research - Modern Chinese Medicine ·(unknown), Bin Liu, (unknown), (unknown), (unknown), Jing Ji, Yaping Xu, (unknown)	4
6	Design, synthesis and anticancer evaluation of imamine-1,3,5-triazine derivatives 2024 ·New Journal of Chemistry ·(unknown), Jingliang He, Rui Li, Bo Ding, Wenlong Wu, (unknown), Ran He, (unknown), Jing Ji, (unknown)	5
7	Antihypertensive effects of rice peptides involve intestinal microbiome alterations and intestinal inflammation alleviation in spontaneously hypertensive rats 2024 ·Food & Function ·Juan Li, Wei Wei, Xiaomin Ma, Jing Ji, (unknown), (unknown), Yangtai Guan, Libo Zhou, (unknown), Wenhua Huang, Fuguo Liu, Min Zhao	3
8	Design, synthesis and biological evaluation of piperine derivatives as potent antitumor agents 2024 ·Fitoterapia ·Xiujun Wang, Yue Qiao, (unknown), (unknown), Siyi Zhang, (unknown), (unknown), (unknown), Shaojie Ma, (unknown), Jing Ji, Bin Liu	4
9	6PPD-quinone exposure induces neuronal mitochondrial dysfunction to exacerbate Lewy neurites formation induced by α-synuclein preformed fibrils seeding 2023 ·Journal of Hazardous Materials ·Jiacheng Fang, Xiaoxiao Wang, Guodong Cao, (unknown), (unknown), Bolun Wang, Yanhao Zhang, Doudou Zhang, (unknown), Ji Xu, Jing Ji, Fenfen Ji, (unknown), Lei Guo, Min Li, Wenlan Liu, (unknown), Zongwei Cai	58
10	Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety 2023 ·European Journal of Medicinal Chemistry ·Wenjiao Yang, (unknown), Haiguo Sun, Chunhui Wu, (unknown), Jing Ji, Xiangrui Jiang, Jingshan Shen, He Yang, (unknown)	12
11	The atypical ubiquitin ligase RNF31 stabilizes c-Myc via epigenetic inactivation of FBXO32 and promotes cancer development 2023 ·Cellular Signalling ·Zefeng Chen, (unknown), (unknown), Yuxin Xu, (unknown), (unknown), Wen Shi, (unknown), (unknown), Xinhui Ma, (unknown), Yuanyuan Ding, Ting Geng, (unknown), Wei Liu, Shunfang Liu, Jing Ji	1
12	Structural application of engineered cementitious composites (ECC): A state-of-the-art review 2023 ·Construction and Building Materials ·Jing Ji, (unknown), (unknown), Lingzhi Li, (unknown), Yao Ding, Kequan Yu	79
13	Treatment and prognostic risk factors for intracranial infection after craniocerebral surgery 2023 ·Neurosurgical Review ·(unknown), Xiaohui Zhi, (unknown), Lin Zhao, Jing Ji	4
14	Altered gut microbiome associated with metabolic-associated fatty liver disease in Chinese children 2023 ·Clinical Nutrition ·Jing Ji, Jiahong Sun, Juan Li, (unknown), Bo Xi, Min Zhao	5
15	PI3K/mTOR inhibitors promote G6PD autophagic degradation and exacerbate oxidative stress damage to radiosensitize small cell lung cancer 2023 ·Cell Death and Disease ·Huan Deng, Yamei Chen, Wang Li, Yibi Zhang, (unknown), Peijing Li, Peng Zhang, Jing Ji, Hai Song, Ming Chen, (unknown)	37
16	Synthesis and biological evaluation of novel aromatic amide derivatives as potential BCR-ABL inhibitors 2023 ·Bioorganic & Medicinal Chemistry Letters ·Xiu Jun Wang, (unknown), (unknown), (unknown), (unknown), (unknown), Huijie Chen, Wentao Jiang, Jing Ji, Mingli Yang	5
17	Design, synthesis and antitumor evaluation of 3‑chloro-4 - (pyridin-2-ylmethoxy) aniline derivatives as BCR-ABL kinase 2023 ·Journal of Molecular Structure ·Xiu Jun Wang, (unknown), Zhen Zhang, (unknown), (unknown), Lu Zheng, Shaojie Ma, (unknown), (unknown), (unknown), Jing Ji, Mingli Yang	1
18	In vitro and in vivo evaluation of a water‐in‐oil microemulsion of platycodin D 2021 ·Archiv der Pharmazie ·Jinyang Shen, (unknown), (unknown), (unknown), Ye Jin, Di Zhang, (unknown), Jing Ji, Jiaojiao Li	3
19	Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesis 2021 ·Cell Death and Differentiation ·Ping Liu, Xiaoji Cong, Shengjie Liao, (unknown), Xiaomin Wang, Wei Dai, Linhui Zhai, (unknown), Jing Ji, Duan Ni, Zhiwei Liu, Yulu Chen, Lulu Pan, Wei Liu, Jian Zhang, Min Huang, Bin Liu, Minjia Tan	29
20	Salinity stress tissue-regenerated Rosa chinensis Jacq. improves water and proline content 2011 ·African Journal of Agricultural Research ·(unknown), Jing Ji, Gang Wang, Jiang Wu	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact